{
  "created_at": "Wed Jan 05 10:36:19 +0000 2022",
  "id_str": "1478660913150500865",
  "full_text": "The triumph of the Oxford-AstraZeneca vaccine https://t.co/5nJLRX5zpg",
  "display_text_range": [
    0,
    69
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/5nJLRX5zpg",
        "expanded_url": "https://econ.st/3ERU7fB",
        "display_url": "econ.st/3ERU7fB",
        "indices": [
          46,
          69
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 37,
  "favorite_count": 78,
  "possibly_sensitive": false,
  "original_created_at": "Wed Jan 05 09:33:28 +0000 2022",
  "localize": [
    {
      "locale": "ja",
      "full_text": "オックスフォード・アストラゼネカ社のワクチンの勝利 https://t.co/5nJLRX5zpg"
    },
    {
      "locale": "zh",
      "full_text": "牛津-阿斯利康疫苗的胜利https://t.co/5nJLRX5zpg"
    },
    {
      "locale": "zh-Hant",
      "full_text": "牛津-阿斯利康疫苗的勝利https://t.co/5nJLRX5zpg"
    }
  ]
}